WEKO3
アイテム
{"_buckets": {"deposit": "a69b29cb-db93-49ff-9b6d-87d37bb51b99"}, "_deposit": {"created_by": 1, "id": "49373", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "49373"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00049373", "sets": ["1"]}, "author_link": ["498586", "498580", "498576", "498589", "498588", "498590", "498579", "498578", "498583", "498582", "498574", "498573", "498598", "498585", "498584", "498592", "498575", "498591", "498581", "498572", "498595", "498597", "498587", "498593", "498594", "498577", "498596"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2017-12", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "12", "bibliographicPageEnd": "2429", "bibliographicPageStart": "2422", "bibliographicVolumeNumber": "108", "bibliographic_titles": [{"bibliographic_title": "Cancer science"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The treatment outcomes of patients with high-risk localized prostate cancer (PC) after carbon-ion radiotherapy (CIRT) combined with long-term androgen deprivation therapy (LTADT) were analyzed, and compared with those of other treatment modalities, focusing on PC-specific mortality (PCSM). A total of 1247 patients were enrolled in three phase II clinical trials of fixed-dose CIRT between 2000 and 2013. Excluding patients with T4 disease, 608 patients with high- or very-high-risk PC, according to the National Comprehensive Cancer Network classification system, who received CIRT with LTADT were evaluated. The median follow-up was 88.4 months, and the 5-/10-year PCSM rates were 1.5%/4.3%, respectively. T3b disease, Gleason score of 9-10, and percentage of positive biopsy cores \u003e 75% were associated with significantly higher PCSM on univariate and multivariate analyses. The 10-year PCSM rates of patients having all three (n=16), two (n=74), or one of these risk factors (n=217) were 27.1%, 11.6%, and 5.7%, respectively. Of the 301 patients with none of these factors, only 1 PCSM occurred over the 10-year follow-up (10-year PCSM rate, 0.3%), and significant differences were observed among the four stratified groups (p \u003c 0.001). CIRT combined with LTADT yielded relatively favorable treatment outcomes in patients with high-risk PC and very favorable results in patients without any of the three abovementioned factors for PCSM. Because a significant difference in PCSM among the high-risk PC patient groups was observed, new categorization and treatment intensity adjustment may be required for high-risk PC patients treated with CIRT. This article is protected by copyright. All rights reserved.", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Wiley Publishing on behalf of the Japanese Cancer Association"}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "28921785", "subitem_relation_type_select": "PMID"}}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1111/cas.13402", "subitem_relation_type_select": "DOI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1347-9032", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kasuya, Goro"}], "nameIdentifiers": [{"nameIdentifier": "498572", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ishikawa, Hitoshi"}], "nameIdentifiers": [{"nameIdentifier": "498573", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsuji, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "498574", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Haruyama, Yasuo"}], "nameIdentifiers": [{"nameIdentifier": "498575", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kobashi, Gen"}], "nameIdentifiers": [{"nameIdentifier": "498576", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ebner, Daniel"}], "nameIdentifiers": [{"nameIdentifier": "498577", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Akakura, Kouichirou"}], "nameIdentifiers": [{"nameIdentifier": "498578", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Suzuki, Hiroyoshi"}], "nameIdentifiers": [{"nameIdentifier": "498579", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tomohiko, Ichikawa"}], "nameIdentifiers": [{"nameIdentifier": "498580", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shimazaki, Jun"}], "nameIdentifiers": [{"nameIdentifier": "498581", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Makishima, Hirokazu"}], "nameIdentifiers": [{"nameIdentifier": "498582", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nomiya, Takuma"}], "nameIdentifiers": [{"nameIdentifier": "498583", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "498584", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsujii, Hirohiko"}], "nameIdentifiers": [{"nameIdentifier": "498585", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "粕谷 吾朗", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498586", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "石川 仁", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498587", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻 比呂志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498588", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "春山 康夫", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498589", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "小橋 元", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498590", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "エブナー ダニエル", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498591", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "赤倉 功一郎", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498592", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "市川 智彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498593", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "島崎 淳", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498594", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "牧島 弘和", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498595", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "野宮 琢磨", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498596", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鎌田 正", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498597", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井 博彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "498598", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/49373", "pubdate": {"attribute_name": "公開日", "attribute_value": "2018-12-28"}, "publish_date": "2018-12-28", "publish_status": "0", "recid": "49373", "relation": {}, "relation_version_is_last": true, "title": ["Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy"], "weko_shared_id": -1}
Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy
https://repo.qst.go.jp/records/49373
https://repo.qst.go.jp/records/49373dd8788b7-26de-49cb-a825-d08af4124b25
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2018-12-28 | |||||
タイトル | ||||||
タイトル | Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Kasuya, Goro
× Kasuya, Goro× Ishikawa, Hitoshi× Tsuji, Hiroshi× Haruyama, Yasuo× Kobashi, Gen× Ebner, Daniel× Akakura, Kouichirou× Suzuki, Hiroyoshi× Tomohiko, Ichikawa× Shimazaki, Jun× Makishima, Hirokazu× Nomiya, Takuma× Kamada, Tadashi× Tsujii, Hirohiko× 粕谷 吾朗× 石川 仁× 辻 比呂志× 春山 康夫× 小橋 元× エブナー ダニエル× 赤倉 功一郎× 市川 智彦× 島崎 淳× 牧島 弘和× 野宮 琢磨× 鎌田 正× 辻井 博彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The treatment outcomes of patients with high-risk localized prostate cancer (PC) after carbon-ion radiotherapy (CIRT) combined with long-term androgen deprivation therapy (LTADT) were analyzed, and compared with those of other treatment modalities, focusing on PC-specific mortality (PCSM). A total of 1247 patients were enrolled in three phase II clinical trials of fixed-dose CIRT between 2000 and 2013. Excluding patients with T4 disease, 608 patients with high- or very-high-risk PC, according to the National Comprehensive Cancer Network classification system, who received CIRT with LTADT were evaluated. The median follow-up was 88.4 months, and the 5-/10-year PCSM rates were 1.5%/4.3%, respectively. T3b disease, Gleason score of 9-10, and percentage of positive biopsy cores > 75% were associated with significantly higher PCSM on univariate and multivariate analyses. The 10-year PCSM rates of patients having all three (n=16), two (n=74), or one of these risk factors (n=217) were 27.1%, 11.6%, and 5.7%, respectively. Of the 301 patients with none of these factors, only 1 PCSM occurred over the 10-year follow-up (10-year PCSM rate, 0.3%), and significant differences were observed among the four stratified groups (p < 0.001). CIRT combined with LTADT yielded relatively favorable treatment outcomes in patients with high-risk PC and very favorable results in patients without any of the three abovementioned factors for PCSM. Because a significant difference in PCSM among the high-risk PC patient groups was observed, new categorization and treatment intensity adjustment may be required for high-risk PC patients treated with CIRT. This article is protected by copyright. All rights reserved. | |||||
書誌情報 |
Cancer science 巻 108, 号 12, p. 2422-2429, 発行日 2017-12 |
|||||
出版者 | ||||||
出版者 | Wiley Publishing on behalf of the Japanese Cancer Association | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1347-9032 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 28921785 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1111/cas.13402 |